-
1
-
-
69949166547
-
A comparison of HIV-1 drug susceptibility as provided by conventional phenotyping and by a phenotype prediction tool based on viral genotype
-
Van Houtte M, Picchio G, Van der Borght K, Pattery T, Lecocq P, Bacheler L: A comparison of HIV-1 drug susceptibility as provided by conventional phenotyping and by a phenotype prediction tool based on viral genotype. J Med Virol 2009;81:1702-1709.
-
(2009)
J Med Virol
, vol.81
, pp. 1702-1709
-
-
Van Houtte, M.1
Picchio, G.2
Van Der Borght, K.3
Pattery, T.4
Lecocq, P.5
Bacheler, L.6
-
2
-
-
0344474694
-
A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs
-
Hertogs K, de Béthune M-P, Miller V, Ivens T, Schel P, Van Cauwenberge A, Van den Eynde C, van Gerwen V, Azijn H, van Houtte M, Peeters F, Staszewski S, Conant M, Bloor S, Kemp S, Larder B, Pauwels R: A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs. Antimicrob Agents Chemother 1998;42:269-276.
-
(1998)
Antimicrob Agents Chemother
, vol.42
, pp. 269-276
-
-
Hertogs, K.1
De Béthune, M.-P.2
Miller, V.3
Ivens, T.4
Schel, P.5
Van Cauwenberge, A.6
Van Den Eynde, C.7
Van Gerwen, V.8
Azijn, H.9
Van Houtte, M.10
Peeters, F.11
Staszewski, S.12
Conant, M.13
Bloor, S.14
Kemp, S.15
Larder, B.16
Pauwels, R.17
-
3
-
-
34547841291
-
Prediction of HIV-1 drug susceptibility phenotype from the viral genotype using linear regression modeling
-
Virco Clinical Response Collaborative Team
-
Vermeiren H, Van Craenenbroeck E, Alen P, Bacheler L, Picchio G, Lecocq P, Virco Clinical Response Collaborative Team: Prediction of HIV-1 drug susceptibility phenotype from the viral genotype using linear regression modeling. J Virol Methods 2007;145:47-55.
-
(2007)
J Virol Methods
, vol.145
, pp. 47-55
-
-
Vermeiren, H.1
Van Craenenbroeck, E.2
Alen, P.3
Bacheler, L.4
Picchio, G.5
Lecocq, P.6
-
4
-
-
0028085161
-
Recombinant virus assay: A rapid, phenotypic assay for assessment of drug susceptibility of human immunodeficiency virus type 1 isolates
-
Kellam P, Larder BA: Recombinant virus assay: a rapid, phenotypic assay for assessment of drug susceptibility of human immunodeficiency virus type 1 isolates. Antimicrob Agents Chemother 1994;38:23-30.
-
(1994)
Antimicrob Agents Chemother
, vol.38
, pp. 23-30
-
-
Kellam, P.1
Larder, B.A.2
-
5
-
-
0021821677
-
A molecular clone of HTLVIII with biological activity
-
Fisher AG, Collalti E, Ratner L, Gallo RC, Wong-Staal F: A molecular clone of HTLVIII with biological activity. Nature 1985;316:262-265.
-
(1985)
Nature
, vol.316
, pp. 262-265
-
-
Fisher, A.G.1
Collalti, E.2
Ratner, L.3
Gallo, R.C.4
Wong-Staal, F.5
-
6
-
-
79957970374
-
HIV-1 nucleotide mixture detection in the vircoTYPE HIV-1 genotyping assay: A comparison between Sanger sequencing and 454 pyrosequencing
-
De Wolf H, Van Marck H, Mostmans W, Thys K, Vandenbroucke I, Van Eygen V, Pattery T, Verhasselt P, Aerssens J: HIV-1 nucleotide mixture detection in the vircoTYPE HIV-1 genotyping assay: a comparison between Sanger sequencing and 454 pyrosequencing. J Virol Methods 2011;175:129-132.
-
(2011)
J Virol Methods
, vol.175
, pp. 129-132
-
-
De Wolf, H.1
Van Marck, H.2
Mostmans, W.3
Thys, K.4
Vandenbroucke, I.5
Van Eygen, V.6
Pattery, T.7
Verhasselt, P.8
Aerssens, J.9
-
7
-
-
42649118796
-
Determination of clinically relevant cutoffs for HIV-1 phenotypic resistance estimates through a combined analysis of clinical trial and cohort data
-
Winters B, Montaner J, Harrigan PR, Gazzard B, Pozniak A, Miller M-grave, Emery S, van Leth F, Robinson P, Baxter J-grave, Perez-Elias M, Castor D, Hammer S, Rinehart A, Vermeiren H, Van Craenenbroeck E, Bacheler LT: Determination of clinically relevant cutoffs for HIV-1 phenotypic resistance estimates through a combined analysis of clinical trial and cohort data. J Acquir Immune Defic Syndr 2008;48:26-34.
-
(2008)
J Acquir Immune Defic Syndr
, vol.48
, pp. 26-34
-
-
Winters, B.1
Montaner, J.2
Harrigan, P.R.3
Gazzard, B.4
Pozniak, A.5
Miller, M.D.6
Emery, S.7
Van Leth, F.8
Robinson, P.9
Baxter, J.D.10
Perez-Elias, M.11
Castor, D.12
Hammer, S.13
Rinehart, A.14
Vermeiren, H.15
Van Craenenbroeck, E.16
Bacheler, L.T.17
-
8
-
-
84856477894
-
Optimized primers combined with ultra-sensitive RNA extraction and amplification methods result in highly successful amplification of the protease and reverse transcriptase genes
-
Sariselkä
-
Nauwelaers D, Van Kerckhove B, Verhofstede C, Pattery T, McKenna P, Hertogs K, De Bethune M-P, Stuyver L: Optimized primers combined with ultra-sensitive RNA extraction and amplification methods result in highly successful amplification of the protease and reverse transcriptase genes. ESCV 2008. Clinical Virology Annual Meeting, Sariselkä, 2008, poster No. P2-36.
-
(2008)
ESCV 2008. Clinical Virology Annual Meeting
-
-
Nauwelaers, D.1
Van Kerckhove, B.2
Verhofstede, C.3
Pattery, T.4
McKenna, P.5
Hertogs, K.6
De Bethune, M.-P.7
Stuyver, L.8
-
9
-
-
84856500333
-
Effect of haemolysis on HIV-1 protease and reverse transcriptase genotyping and phenotyping success: A two-year analysis
-
Glasgow
-
Pattery T, Bovee I, Rousseau E, Hartmans N, Mc Kenna P: Effect of haemolysis on HIV-1 protease and reverse transcriptase genotyping and phenotyping success: a two-year analysis. HIV9-9th International Congress on Drug Therapy in HIV Infection, Glasgow, 2008, poster No. 208.
-
(2008)
HIV9-9th International Congress on Drug Therapy in HIV Infection
, pp. 208
-
-
Pattery, T.1
Bovee, I.2
Rousseau, E.3
Hartmans, N.4
Kenna, P.M.5
-
10
-
-
84856473142
-
Effect of lipemia and bilirubinemia on HIV-1 protease and reverse transcriptase genotyping and phenotyping success: A 5-year analysis
-
Glasgow
-
Pattery T, Van Cauwenberge A, Van Hove M, Smits V, Van Soom K, Villacian J: Effect of lipemia and bilirubinemia on HIV-1 protease and reverse transcriptase genotyping and phenotyping success: a 5-year analysis. HIV10-10th International Congress on Drug Therapy in HIV Infection, Glasgow, 2010, poster No. 148.
-
(2010)
HIV10-10th International Congress on Drug Therapy in HIV Infection
, pp. 148
-
-
Pattery, T.1
Van Cauwenberge, A.2
Van Hove, M.3
Smits, V.4
Van Soom, K.5
Villacian, J.6
-
11
-
-
84856420287
-
Efficiency of HIV-1 PR-RT genotyping is not impacted by co-infection with HCV
-
Glasgow
-
Deloof A, De Wolf H, Verlinden Y, Van Den Berg K, Villacian J, Pattery T: Efficiency of HIV-1 PR-RT genotyping is not impacted by co-infection with HCV. HIV10-10th International Congress on Drug Therapy in HIV Infection, Glasgow, 2010, poster No. 212.
-
(2010)
HIV10-10th International Congress on Drug Therapy in HIV Infection
, pp. 212
-
-
Deloof, A.1
De Wolf, H.2
Verlinden, Y.3
Van Den Berg, K.4
Villacian, J.5
Pattery, T.6
-
12
-
-
33745081536
-
Successful use of genotypic resistance testing in HIV-1 infected individuals with detectable viraemia between 50 and 1000 copies/ml
-
Waters L, Mandalia S, Asboe D: Successful use of genotypic resistance testing in HIV-1 infected individuals with detectable viraemia between 50 and 1000 copies/ml. AI-graveS 2006;20:778-779.
-
(2006)
AI-graveS
, vol.20
, pp. 778-779
-
-
Waters, L.1
Mandalia, S.2
Asboe, D.3
-
13
-
-
84856477895
-
Efficiency of HIV-1 PR-RT genotyping on clinical isolates with viral load less than 1, 000 copies:ml
-
Sorrento, oral session and poster No. 1
-
Pattery T, De Wolf H, Verlinden Y, McKenna P, Van Houtte M, Bacheler L, Villacian J: Efficiency of HIV-1 PR-RT genotyping on clinical isolates with viral load less than 1, 000 copies:ml. 8th European HIV Drug Resistance Workshop, Sorrento, 2010, oral session and poster No. 1.
-
(2010)
8th European HIV Drug Resistance Workshop
-
-
Pattery, T.1
De Wolf, H.2
Verlinden, Y.3
McKenna, P.4
Van Houtte, M.5
Bacheler, L.6
Villacian, J.7
-
14
-
-
0023687234
-
Rapid and automated tetrazoliumbased calorimetric assay for the detection of anti-HIV compounds
-
Pauwels R, Balzarini J, Baba M, Snoeck R, Schols D, Herdewijn P, Desmyter J, De Clercq E: Rapid and automated tetrazoliumbased calorimetric assay for the detection of anti-HIV compounds. J Virol Methods 1988;20:309-321.
-
(1988)
J Virol Methods
, vol.20
, pp. 309-321
-
-
Pauwels, R.1
Balzarini, J.2
Baba, M.3
Snoeck, R.4
Schols, D.5
Herdewijn, P.6
Desmyter, J.7
De Clercq, E.8
-
16
-
-
70349745177
-
Clinical cut-offs for HIV-1 phenotypic resistance estimates: Update based on recent pivotal clinical trial data and a revised approach to viral mixtures
-
Winters B, Van Craenenbroeck E, Van den Borght K, Lecocq P, Villacian J, Bacheler L: Clinical cut-offs for HIV-1 phenotypic resistance estimates: update based on recent pivotal clinical trial data and a revised approach to viral mixtures. J Virol Methods 2009;162:101-108.
-
(2009)
J Virol Methods
, vol.162
, pp. 101-108
-
-
Winters, B.1
Van Craenenbroeck, E.2
Van Den Borght, K.3
Lecocq, P.4
Villacian, J.5
Bacheler, L.6
-
17
-
-
84856477898
-
Reproducibility of a highthroughput HIV-1 genotypic resistance assay over time (2001-2007)
-
Glasgow, poster
-
Deloof A, Muyldermans G, Pattery T, McKenna P, Van Cauwenberge A, De Wolf H, Van Houtte M: Reproducibility of a highthroughput HIV-1 genotypic resistance assay over time (2001-2007). HIV9-9th International Congress on Drug Therapy in HIV Infection, Glasgow, 2008, poster No. 205.
-
(2008)
HIV9-9th International Congress on Drug Therapy in HIV Infection
, Issue.205
-
-
Deloof, A.1
Muyldermans, G.2
Pattery, T.3
McKenna, P.4
Van Cauwenberge, A.5
De Wolf, H.6
Van Houtte, M.7
-
18
-
-
84856477899
-
Assessment of the performance of the vircoTYPE system in an independent clinical dataset
-
Barbados, poster
-
Winters B, Montaner J, Harrigan PR, Gazzard B, Pozniak A, Van der Borght K, Villacian J, Bacheler L: Assessment of the performance of the vircoTYPE system in an independent clinical dataset. XVI International HIV Drug Resistance Workshop, Barbados, 2007, poster No. 155.
-
(2007)
XVI International HIV Drug Resistance Workshop
, Issue.155
-
-
Winters, B.1
Montaner, J.2
Harrigan, P.R.3
Gazzard, B.4
Pozniak, A.5
Van Der Borght, K.6
Villacian, J.7
Bacheler, L.8
-
19
-
-
33746555576
-
HIV/AI-graveS epidemiology, pathogenesis, prevention, and treatment
-
Simon V, Ho D-grave, Abdool Karim Q: HIV/AI-graveS epidemiology, pathogenesis, prevention, and treatment. Lancet 2006;368:489-504.
-
(2006)
Lancet
, vol.368
, pp. 489-504
-
-
Simon, V.1
Ho, D.D.2
Karim, Q.A.3
-
20
-
-
1442355578
-
HIV drug resistance
-
Clavel F, Hance AJ: HIV drug resistance. N Engl J Med 2004;350:1023-1035.
-
(2004)
N Engl J Med
, vol.350
, pp. 1023-1035
-
-
Clavel, F.1
Hance, A.J.2
-
21
-
-
33646744181
-
Web resources for HIV type 1 genotypic-resistance test interpretation
-
Liu TF, Shafer RW: Web resources for HIV type 1 genotypic-resistance test interpretation. Clin Infect Dis 2006;42:1608-1618.
-
(2006)
Clin Infect Dis
, vol.42
, pp. 1608-1618
-
-
Liu, T.F.1
Shafer, R.W.2
|